{"id":"W4242436944","doi":"10.1200/jco.2014.32.15_suppl.10528","title":"Phase II study of oral ENMD-2076 administered to patients (pts) with advanced soft tissue sarcoma (STS).","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"SickKids Foundation; University Health Network; University of Toronto; Mount Sinai Hospital; Hospital for Sick Children; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Adverse effect; Sarcoma; Soft tissue sarcoma; Internal medicine; Trabectedin; Phases of clinical research; Gemcitabine; Pazopanib; Response Evaluation Criteria in Solid Tumors; Progressive disease; Surgery; Oncology; Clinical trial; Cancer; Gastroenterology; Chemotherapy; Pathology; Sunitinib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006257312,0.0008705922,0.001441612,0.0003142602,0.0002664174,0.0006048042,0.0005628772,0.0006981705,0.005314284],"category_scores_gemma":[0.0003625154,0.0003757462,0.0004733726,0.0003086328,0.0005239939,0.0003934008,0.0002682313,0.001868683,0.001302482],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005340687,"about_ca_system_score_gemma":0.001451391,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007726987,"about_ca_topic_score_gemma":0.002358176,"domain_scores_codex":[0.9998382,0.00006681861,0.000008225443,0.00002782536,0.00002141182,0.00003739747],"domain_scores_gemma":[0.9997161,0.00004442254,0.00004395003,0.00001975542,0.00002258062,0.0001532382],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5475211,0.1432797,0.01212079,0.001504955,0.001033121,0.0007298505,0.0003813474,0.004862868,0.09144168,0.0006588539,0.01123536,0.1852304],"study_design_scores_gemma":[0.3681538,0.6015781,0.01397838,0.00005826808,0.0002741064,0.0007420467,0.00009342673,0.002110153,0.006288945,0.0002488769,0.006450697,0.00002331229],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9919819,0.001088038,0.0005831418,0.0002821498,0.00009467839,0.002216557,0.00113546,0.0001129654,0.002505045],"genre_scores_gemma":[0.9843126,0.001364343,0.002003116,0.0007555836,0.0001085967,0.002523322,0.003718404,0.00003151054,0.005182504],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005314284,"threshold_uncertainty_score":0.0177781,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0997142638469942,"score_gpt":0.4863031168600618,"score_spread":0.3865888530130676,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}